Christophe Ampe

Prof. Dr. Christophe Ampe

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
DTDavina Tondeleir
Davina Tondeleir
ALAnja Lambrechts
Anja Lambrechts
MMMatthias Müller
Matthias Müller
VJVeronique Jonckheere
Veronique Jonckheere
TDThierry Doll
Thierry Doll
CAChristophe Ampe
Christophe Ampe
Vertebrate nonmuscle cells express two actin isoforms: cytoplasmic β- and γ-actin. Because of the presence and localized translation of β-actin at the leading edge, this isoform is generally accepted to specifically generate protrusive forces for cell migration. Recent evidence also implicates β-actin in gene regulation. Cell migration without β-actin has remained unstudied until recently and it is unclear whether other actin isoforms can compensate for this cytoplasmic function and/or for its nuclear role. Primary mouse embryonic fibroblasts lacking β-actin display compensatory expression of other actin isoforms. Consistent with this preservation of polymerization capacity, β-actin knockout cells have unchanged lamellipodial protrusion rates despite a severe migration defect. To solve this paradox we applied quantitative proteomics revealing a broad genetic reprogramming of β-actin knockout cells. This also explains why reintroducing β-actin in knockout cells does not restore the affected cell migration. Pathway analysis suggested increased Rho-ROCK signaling, consistent with observed phenotypic changes. We therefore developed and tested a model explaining the phenotypes in β-actin knockout cells based on increased Rho-ROCK signaling and increased TGFβ production resulting in increased adhesion and contractility in the knockout cells. Inhibiting ROCK or myosin restores migration of β-actin knockout cells indicating that other actins compensate for β-actin in this process. Consequently, isoactins act redundantly in providing propulsive forces for cell migration, but β-actin has a unique nuclear function, regulating expression on transcriptional and post-translational levels, thereby preventing myogenic differentiation.

1 May 2004 in Protein Science
Verified
Journal Article
Open access
PDF file
WVWim Vermeulen
Wim Vermeulen
PVPeter Vanhaesebrouck
Peter Vanhaesebrouck
MTMarleen Van Troys
Marleen Van Troys
MVMieke Verschueren
Mieke Verschueren
FFFranky Fant
Franky Fant
FBFrans A.M. Borremans
Frans A.M. Borremans
Protein Science, the flagship journal of The Protein Society, serves an international forum for publishing original reports on all scientific aspects of protein molecules. The Journal publishes papers by leading scientists from all over the world that report on advances in the understanding of proteins in the broadest sense. Protein Science aims to unify this field by cutting across established disciplinary lines and focusing on “protein-centered” science.

29 November 2005 in Cell Motility
Verified
Journal Article
Closed access
PDF file
DPD. Polet
D. Polet
ALA. Lambrechts
A. Lambrechts
KOK. Ono
K. Ono
AMA. Mah
A. Mah
FPF. Peelman
F. Peelman
SOS. Ono
S. Ono

19 October 2016
Verified
Book Chapter
Closed access
PDF file
CAChristophe Ampe
Christophe Ampe
MTMarleen Van Troys
Marleen Van Troys

17 September 2018 in Cancers
Verified
Journal Article
Open access
PDF file
ASAleksandra Simiczyjew
Aleksandra Simiczyjew
EDEwelina Dratkiewicz
Ewelina Dratkiewicz
MTMarleen Van Troys
Marleen Van Troys
CAChristophe Ampe
Christophe Ampe
ISIlona Styczeń
Ilona Styczeń
DNDorota Nowak
Dorota Nowak
Triple-negative breast cancer (TNBC) is the most challenging subtype to treat due to the lack of estrogen receptor, progesterone receptor, and HER2 expression, which excludes the usage of directed targeted therapy against them. Promising therapeutic targets are the hepatocyte growth factor receptor (MET) and epidermal growth factor receptor (EGFR), which expression is frequently elevated in TNBC. Inhibitors of these receptors used as monotherapy are often ineffective. Due to that, we studied the efficacy of combined therapy targeting MET and EGFR simultaneously. Two TNBC cell lines were treated with lapatinib (a dual EGFR and HER2 inhibitor), foretinib (a MET inhibitor), or a combination of the two. After the inhibitors treatment, we verified the cell viability (XTT assay), distribution of the cell cycle phases, the activation of signaling pathways (Western blotting), distribution of invadopodia, fluorescent gelatin digestion (immunofluorescence), and the invasion capacity of cells. A combination of foretinib and lapatinib effectively reduced the viability of examined cells, led to G2/M arrest and reduction of pAKT. There was also a decreasein number of invadopodia formed by cells, their ability to digest gelatin and reduction of cells migration/invasion capacity. Therapy targeting of both EGFR and MET receptors was much more effective against tested cells than monotherapy. We selected a combination of drugs that could be successfully used against this breast cancer subtype.

7 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DTDavina Tondeleir
Davina Tondeleir
RNRivka Noelanders
Rivka Noelanders
KBKarima Bakkali
Karima Bakkali
CAChristophe Ampe
Christophe Ampe
The mouse genome consists of six functional actin genes of which the expression patterns are temporally and spatially regulated during development and in the adult organism. Deletion of beta-actin in mouse is lethal during embryonic development, although there is compensatory expression of other actin isoforms. This suggests different isoform specific functions and, more in particular, an important function for beta-actin during early mammalian development. We here report a role for beta-actin during neural crest ontogeny. Although beta-actin null neural crest cells show expression of neural crest markers, less cells delaminate and their migration arrests shortly after. These phenotypes were associated with elevated apoptosis levels in neural crest cells, whereas proliferation levels were unchanged. Specifically the pre-migratory neural crest cells displayed higher levels of apoptosis, suggesting increased apoptosis in the neural tube accounts for the decreased amount of migrating neural crest cells seen in the beta-actin null embryos. These cells additionally displayed a lack of membrane bound N-cadherin and dramatic decrease in cadherin-11 expression which was more pronounced in the pre-migratory neural crest population, potentially indicating linkage between the cadherin-11 expression and apoptosis. By inhibiting ROCK ex vivo, the knockout neural crest cells regained migratory capacity and cadherin-11 expression was upregulated. We conclude that the presence of beta-actin is vital for survival, specifically of pre-migratory neural crest cells, their proper emigration from the neural tube and their subsequent migration. Furthermore, the absence of beta-actin affects cadherin-11 and N-cadherin function, which could partly be alleviated by ROCK inhibition, situating the Rho-ROCK signaling in a feedback loop with cadherin-11.